Eli Lilly will build the new site as an advanced pharmaceutical facility for the production of injectable products and delivery devices


Eli Lilly and Company corporate centre in Indianapolis, Indiana. (Credit: Momoneymoproblemz/Wikipedia.)

Eli Lilly and Company (Lilly) has unveiled its plans to construct a new pharmaceutical manufacturing facility at Research Triangle Park in Durham, North Carolina.

The healthcare and biopharmaceutical company is said to be committed to investing more than $470m in the new manufacturing facility and creating more than 460 new jobs in positions including scientists, engineers, quality professionals and manufacturing operations.

North Carolina Governor Roy Cooper said: “Life science companies like Lilly continue to choose North Carolina. Our exceptional workforce draws global companies as we continue to grow North Carolina into a worldwide hub for the biotechnology industry.”

Lilly owns seven manufacturing sites in Indiana, New Jersey and Puerto Rico, in US

Lilly intends to build new manufacturing as an advanced pharmaceutical facility for the production of injectable products and delivery devices.

The company said that the North Carolina Department of Commerce has provided support during its site evaluation and decision-making process.

In addition, its North Carolina project will be partly supported by a Job Development Investment Grant (JDIG), which has been approved by the N.C. Economic Investment Committee.

The JDIG will be valid for a term of 12 years, and the project is expected to boost the economy of North Carolina by $4.1bn and supports the economically challenged communities in the state.

Lilly chairman and chief executive officer David A Ricks said: “This next-generation manufacturing facility will allow us to expand our capacity to make the Lilly medicines that are helping people with serious illnesses today, and help us prepare for new medicines coming from our robust pipeline in the future.

“In the past two years, we have invested billions of capital in new U.S.-based manufacturing because the 2017 tax reform rebalanced the playing field in favour of the American worker. We’re excited to be bringing more of these high-skill, high-wage advanced manufacturing jobs to North Carolina.”